Annalise Enterprise CXR granted CE Mark under MDR class IIb for clinical use in EU
Update: Annalise.ai is now “Harrison-AI Medical Pty Ltd
We’re delighted to announce that Annalise Enterprise CXR has been granted CE Mark under MDR class IIb for clinical use in the European Union. Annalise Enterprise CXR is the most comprehensive AI decision-support solution for chest X-rays to have received CE Marking under MDR to date.
“The MDR Class IIb CE Marking is a more rigorous assessment of medical device patient safety for radiology in EU and its award is a testament to our commitment to deliver quality comprehensive solutions.” comments Dr Rick Abramson, Chief Medical Officer at annalise.ai.
About Harrison.ai
Harrison.ai is a global healthcare technology company on a mission to urgently scale healthcare capacity through AI-powered medical imaging diagnostic support and workflow solutions. Its radiology (Annalise.ai) and pathology (Franklin.ai) solutions help clinicians deliver faster, more accurate diagnoses, aiding in the early detection of cancer and other medical conditions. Harrison.ai partners with hospitals and private clinics across APAC, EMEA, the United Kingdom and United States. For more information, visit Harrison.ai.
